In related news, WHO spokesperson Gregory Hartl said Friday that clinical trials have shown the annual production of H1N1 vaccines will be "substantially less" than the 4.9 billion doses vaccines first predicted by the WHO, Reuters reports. Reuters reports. "In a statement, the WHO said current supplies of pandemic vaccine are 'inadequate for a world population in which virtually everyone is susceptible to infection,'" the news service writes (Nebehay, 9/18).

Australia 's H1N1 Vaccination Campaign Will Be Among First To Offer Insight On Public Interest In Vaccine

Bloomberg examines how public health experts will be keeping a close eye on Australia's H1N1 vaccination campaign, scheduled to launch in less than two weeks. The country will be one of the first to deliver the vaccine to its population, allowing public health experts worldwide the opportunity to assess the public's interest in the vaccine (Fenner, Bennett, 9/18).

kaiserhealthnews/

This article is republished with kind permission from our friends at The Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery of in-depth coverage of health policy developments, debates and discussions. The Kaiser Daily Health Policy Report is published for Kaisernetwork, a free service of The Henry J. Kaiser Family Foundation. 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.